This inventor holds 2 USPTO granted patents. Top assignee: Nestec S.a.. Active years: 1997-1998.
Company Filing History:
Years Active: 1997-1998
Title: Mark Y Enslen: Innovator in Sustained Release Caffeine Formulations
Introduction
Mark Y Enslen is a notable inventor based in Yverdon, Switzerland. He has made significant contributions to the field of stimulant formulations, particularly focusing on caffeine. With a total of 2 patents, Enslen's work aims to enhance alertness through innovative delivery methods.
Latest Patents
One of Enslen's latest patents is a sustained release microparticulate caffeine formulation. This invention relates to compositions and methods designed to increase an individual's alertness through the administration of stimulants such as xanthine or its derivatives, with a preference for caffeine. The formulation consists of one or more layers containing the stimulant arranged around the cores of microparticles. This design allows for a significant portion of the stimulant to be released within approximately two hours after administration, achieving a desired level of alertness. Subsequently, the remaining composition is released over a period of 6 to 10 hours, ensuring that the stimulant provides alertness without affecting the individual's ability to sleep. The formulation is meticulously designed to prevent the accumulation of the stimulant in the individual's system.
Career Highlights
Mark Y Enslen is currently associated with Nestec S.A., where he continues to innovate in the field of caffeine formulations. His work has garnered attention for its potential applications in enhancing cognitive performance and alertness.
Collaborations
Enslen has collaborated with notable colleagues, including Francoise Chauffard and Pierre Tachon, contributing to the advancement of research in stimulant formulations.
Conclusion
Mark Y Enslen's innovative work in sustained release caffeine formulations showcases his commitment to enhancing alertness through scientific advancements. His contributions are paving the way for new applications in the field of stimulants.
